These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23254386)
1. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253 [TBL] [Abstract][Full Text] [Related]
3. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer. Zhang W; Jiao H; Zhang X; Zhao R; Wang F; He W; Zong H; Fan Q; Wang L Mol Med Rep; 2015 Jul; 12(1):141-6. PubMed ID: 25738352 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283 [TBL] [Abstract][Full Text] [Related]
6. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863 [TBL] [Abstract][Full Text] [Related]
8. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400 [TBL] [Abstract][Full Text] [Related]
9. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372 [TBL] [Abstract][Full Text] [Related]
10. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Singal R; van Wert J; Bashambu M Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation. Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612 [TBL] [Abstract][Full Text] [Related]
12. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. Oka M; Meacham AM; Hamazaki T; Rodić N; Chang LJ; Terada N Oncogene; 2005 Apr; 24(19):3091-9. PubMed ID: 15735669 [TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase and demethylase in human prostate cancer. Patra SK; Patra A; Zhao H; Dahiya R Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882 [TBL] [Abstract][Full Text] [Related]
14. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168 [TBL] [Abstract][Full Text] [Related]
15. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase and DNA methyltransferase in human prostate cancer. Patra SK; Patra A; Dahiya R Biochem Biophys Res Commun; 2001 Sep; 287(3):705-13. PubMed ID: 11563853 [TBL] [Abstract][Full Text] [Related]
17. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells. Huang HF; Murphy TF; Shu P; Barton AB; Barton BE Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107 [TBL] [Abstract][Full Text] [Related]
18. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia. Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460 [TBL] [Abstract][Full Text] [Related]
19. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327 [TBL] [Abstract][Full Text] [Related]
20. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]